Strategy FVIIa FIX FX/FXa
Increased activity [4,10,16-22,24,35] [37,40-42,44-46] /
Affected membrane affinity [5,25-27] [42,48] /
Prolonged half-life [28-30] [62-64] [65,71,74,75]
FVIII bypass activity / [56-59] /
Thrombin- / auto-activable / / [66,77,78]
Table 1: Summary of references in bioengineering strategies of factor VII, IX and X.